26
MSRP:
Now:
$1,158.50 - $2,586.50
Was:
Cell-permeable. A protein tyrosine kinase (PTK) inhibitor. targeting KIT that is active, orally bioavailable in vivo, and has low toxicity. Masitinib also potently inhibited recombinant PDGFR and the...
26-2007-GEN